Amit Mahipal, MD

Amit Mahipal, MD, University Hospitals Seidman Cancer Center

Articles by Amit Mahipal, MD
First-line Atezolizumab With Bevacizumab for HCC
Amit Mahipal, MDHepatocellular Carcinoma | March 13, 2025
Dr. Amit Mahipal discusses a recent study on atezolizumab plus bevacizumab as a first-line treatment for HCC.
View More
Dr. Amit Mahipal Discusses Liquid Biopsies for Advanced Cholangiocarcinoma at ASCO GI 2024
Amit Mahipal, MDASCO GI 2024 | March 13, 2025
Dr. Amit Mahipal discusses liquid biopsy for advanced cholangiocarcinoma and how it compares to tissue-based testing.
View More
Safety Considerations, Prognostic Factors for Patients with HCC Receiving Lenvatinib After IO
Amit Mahipal, MDHepatocellular Carcinoma | March 13, 2025
Drs. Mahipal and Finn share the safety and prognostic considerations for patients with aHCC receiving lenvatinib after IO.
View More
Real-world Outcomes for Patients with HCC Receiving Lenvatinib After IO
Amit Mahipal, MDHepatocellular Carcinoma | March 13, 2025
Drs. Mahipal and Finn discuss real-world outcomes for hepatocellular carcinoma patients receiving lenvatinib following IO.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |